IL Core Implementation Guide
0.18.0 - draft Israel flag

This page is part of the IL-Core IG (v0.18.0: draft-1 Draft) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

ValueSet: Vaccine Product Codes

Official URL: http://fhir.health.gov.il/ValueSet/vaccine-product-code Version: 0.18.0
Draft as of 2024-06-15 Computable Name: VaccineProductCode

A list of codes for vaccine products from ATC and cvx codeSystems

References

Logical Definition (CLD)

This value set includes codes based on the following rules:

 

Expansion

Expansion based on:

  • codesystem Vaccine Administered Code Set (CVX) version20231214
  • codesystem WHO ATC version2020-05

This value set contains 388 concepts

CodeSystemDisplay
  01http://hl7.org/fhir/sid/cvxDTP
  02http://hl7.org/fhir/sid/cvxOPV
  03http://hl7.org/fhir/sid/cvxMMR
  04http://hl7.org/fhir/sid/cvxM/R
  05http://hl7.org/fhir/sid/cvxmeasles
  06http://hl7.org/fhir/sid/cvxrubella
  07http://hl7.org/fhir/sid/cvxmumps
  08http://hl7.org/fhir/sid/cvxHep B, adolescent or pediatric
  09http://hl7.org/fhir/sid/cvxTd (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
  10http://hl7.org/fhir/sid/cvxIPV
  11http://hl7.org/fhir/sid/cvxpertussis
  12http://hl7.org/fhir/sid/cvxdiphtheria antitoxin
  13http://hl7.org/fhir/sid/cvxTIG
  14http://hl7.org/fhir/sid/cvxIG, unspecified formulation
  15http://hl7.org/fhir/sid/cvxinfluenza, split (incl. purified surface antigen)
  16http://hl7.org/fhir/sid/cvxinfluenza, whole
  17http://hl7.org/fhir/sid/cvxHib, unspecified formulation
  18http://hl7.org/fhir/sid/cvxrabies, intramuscular injection
  19http://hl7.org/fhir/sid/cvxBCG
  20http://hl7.org/fhir/sid/cvxDTaP
  21http://hl7.org/fhir/sid/cvxvaricella
  22http://hl7.org/fhir/sid/cvxDTP-Hib
  23http://hl7.org/fhir/sid/cvxplague
  24http://hl7.org/fhir/sid/cvxanthrax
  25http://hl7.org/fhir/sid/cvxtyphoid, oral
  26http://hl7.org/fhir/sid/cvxcholera, unspecified formulation
  27http://hl7.org/fhir/sid/cvxbotulinum antitoxin
  28http://hl7.org/fhir/sid/cvxDT (pediatric)
  29http://hl7.org/fhir/sid/cvxCMVIG
  30http://hl7.org/fhir/sid/cvxHBIG
  31http://hl7.org/fhir/sid/cvxHep A, pediatric, unspecified formulation
  32http://hl7.org/fhir/sid/cvxmeningococcal MPSV4
  33http://hl7.org/fhir/sid/cvxpneumococcal polysaccharide PPV23
  34http://hl7.org/fhir/sid/cvxRIG
  35http://hl7.org/fhir/sid/cvxtetanus toxoid, adsorbed
  36http://hl7.org/fhir/sid/cvxVZIG
  37http://hl7.org/fhir/sid/cvxyellow fever
  38http://hl7.org/fhir/sid/cvxrubella/mumps
  39http://hl7.org/fhir/sid/cvxJapanese encephalitis SC
  40http://hl7.org/fhir/sid/cvxrabies, intradermal injection
  41http://hl7.org/fhir/sid/cvxtyphoid, parenteral
  42http://hl7.org/fhir/sid/cvxHep B, adolescent/high risk infant
  43http://hl7.org/fhir/sid/cvxHep B, adult
  44http://hl7.org/fhir/sid/cvxHep B, dialysis
  45http://hl7.org/fhir/sid/cvxHep B, unspecified formulation
  46http://hl7.org/fhir/sid/cvxHib (PRP-D)
  47http://hl7.org/fhir/sid/cvxHib (HbOC)
  48http://hl7.org/fhir/sid/cvxHib (PRP-T)
  49http://hl7.org/fhir/sid/cvxHib (PRP-OMP)
  50http://hl7.org/fhir/sid/cvxDTaP-Hib
  51http://hl7.org/fhir/sid/cvxHib-Hep B
  52http://hl7.org/fhir/sid/cvxHep A, adult
  53http://hl7.org/fhir/sid/cvxtyphoid, parenteral, AKD (U.S. military)
  54http://hl7.org/fhir/sid/cvxadenovirus, type 4
  55http://hl7.org/fhir/sid/cvxadenovirus, type 7
  56http://hl7.org/fhir/sid/cvxdengue fever tetravalent
  57http://hl7.org/fhir/sid/cvxhantavirus
  58http://hl7.org/fhir/sid/cvxHep C
  59http://hl7.org/fhir/sid/cvxHep E
  60http://hl7.org/fhir/sid/cvxherpes simplex 2
  61http://hl7.org/fhir/sid/cvxHIV
  62http://hl7.org/fhir/sid/cvxHPV, quadrivalent
  63http://hl7.org/fhir/sid/cvxJunin virus
  64http://hl7.org/fhir/sid/cvxleishmaniasis
  65http://hl7.org/fhir/sid/cvxleprosy
  66http://hl7.org/fhir/sid/cvxLyme disease
  67http://hl7.org/fhir/sid/cvxmalaria
  68http://hl7.org/fhir/sid/cvxmelanoma
  69http://hl7.org/fhir/sid/cvxparainfluenza-3
  70http://hl7.org/fhir/sid/cvxQ fever
  71http://hl7.org/fhir/sid/cvxRSV-IGIV
  72http://hl7.org/fhir/sid/cvxrheumatic fever
  73http://hl7.org/fhir/sid/cvxRift Valley fever
  74http://hl7.org/fhir/sid/cvxrotavirus, tetravalent
  75http://hl7.org/fhir/sid/cvxvaccinia (smallpox)
  76http://hl7.org/fhir/sid/cvxStaphylococcus bacterio lysate
  77http://hl7.org/fhir/sid/cvxTick-borne encephalitis vaccine (non-US)
  78http://hl7.org/fhir/sid/cvxtularemia vaccine
  79http://hl7.org/fhir/sid/cvxvaccinia immune globulin
  80http://hl7.org/fhir/sid/cvxVEE, live
  81http://hl7.org/fhir/sid/cvxVEE, inactivated
  82http://hl7.org/fhir/sid/cvxadenovirus, unspecified formulation
  83http://hl7.org/fhir/sid/cvxHep A, ped/adol, 2 dose
  84http://hl7.org/fhir/sid/cvxHep A, ped/adol, 3 dose
  85http://hl7.org/fhir/sid/cvxHep A, unspecified formulation
  86http://hl7.org/fhir/sid/cvxIG
  87http://hl7.org/fhir/sid/cvxIGIV
  88http://hl7.org/fhir/sid/cvxinfluenza, unspecified formulation
  89http://hl7.org/fhir/sid/cvxpolio, unspecified formulation
  90http://hl7.org/fhir/sid/cvxrabies, unspecified formulation
  91http://hl7.org/fhir/sid/cvxtyphoid, unspecified formulation
  92http://hl7.org/fhir/sid/cvxVEE, unspecified formulation
  93http://hl7.org/fhir/sid/cvxRSV-MAb
  94http://hl7.org/fhir/sid/cvxMMRV
  95http://hl7.org/fhir/sid/cvxTST-OT tine test
  96http://hl7.org/fhir/sid/cvxTST-PPD intradermal
  97http://hl7.org/fhir/sid/cvxTST-PPD tine test
  98http://hl7.org/fhir/sid/cvxTST, unspecified formulation
  99http://hl7.org/fhir/sid/cvxRESERVED - do not use
  100http://hl7.org/fhir/sid/cvxpneumococcal conjugate PCV 7
  101http://hl7.org/fhir/sid/cvxtyphoid, ViCPs
  102http://hl7.org/fhir/sid/cvxDTP-Hib-Hep B
  103http://hl7.org/fhir/sid/cvxmeningococcal C conjugate
  104http://hl7.org/fhir/sid/cvxHep A-Hep B
  105http://hl7.org/fhir/sid/cvxvaccinia (smallpox) diluted
  106http://hl7.org/fhir/sid/cvxDTaP, 5 pertussis antigens
  107http://hl7.org/fhir/sid/cvxDTaP, unspecified formulation
  108http://hl7.org/fhir/sid/cvxmeningococcal ACWY, unspecified formulation
  109http://hl7.org/fhir/sid/cvxpneumococcal, unspecified formulation
  110http://hl7.org/fhir/sid/cvxDTaP-Hep B-IPV
  111http://hl7.org/fhir/sid/cvxinfluenza, live, intranasal
  112http://hl7.org/fhir/sid/cvxtetanus toxoid, unspecified formulation
  113http://hl7.org/fhir/sid/cvxTd (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
  114http://hl7.org/fhir/sid/cvxmeningococcal MCV4P
  115http://hl7.org/fhir/sid/cvxTdap
  116http://hl7.org/fhir/sid/cvxrotavirus, pentavalent
  117http://hl7.org/fhir/sid/cvxVZIG (IND)
  118http://hl7.org/fhir/sid/cvxHPV, bivalent
  119http://hl7.org/fhir/sid/cvxrotavirus, monovalent
  120http://hl7.org/fhir/sid/cvxDTaP-Hib-IPV
  121http://hl7.org/fhir/sid/cvxzoster live
  122http://hl7.org/fhir/sid/cvxrotavirus, unspecified formulation
  123http://hl7.org/fhir/sid/cvxinfluenza, H5N1-1203
  125http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, nasal
  126http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09, preservative-free
  127http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09
  128http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, all formulations
  129http://hl7.org/fhir/sid/cvxJapanese Encephalitis, unspecified formulation
  130http://hl7.org/fhir/sid/cvxDTaP-IPV
  131http://hl7.org/fhir/sid/cvxtyphus, historical
  132http://hl7.org/fhir/sid/cvxDTaP-IPV-HIB-HEP B, historical
  133http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV 13
  134http://hl7.org/fhir/sid/cvxJapanese Encephalitis IM
  135http://hl7.org/fhir/sid/cvxInfluenza, high dose seasonal
  136http://hl7.org/fhir/sid/cvxMeningococcal MCV4O
  137http://hl7.org/fhir/sid/cvxHPV, unspecified formulation
  138http://hl7.org/fhir/sid/cvxTd (adult)
  139http://hl7.org/fhir/sid/cvxTd(adult) unspecified formulation
  140http://hl7.org/fhir/sid/cvxInfluenza, seasonal, injectable, preservative free
  141http://hl7.org/fhir/sid/cvxInfluenza, seasonal, injectable
  142http://hl7.org/fhir/sid/cvxtetanus toxoid, not adsorbed
  143http://hl7.org/fhir/sid/cvxAdenovirus types 4 and 7
  144http://hl7.org/fhir/sid/cvxinfluenza, seasonal, intradermal, preservative free
  145http://hl7.org/fhir/sid/cvxRSV-MAb (new)
  146http://hl7.org/fhir/sid/cvxDTaP,IPV,Hib,HepB
  147http://hl7.org/fhir/sid/cvxmeningococcal MCV4, unspecified formulation
  148http://hl7.org/fhir/sid/cvxMeningococcal C/Y-HIB PRP
  149http://hl7.org/fhir/sid/cvxinfluenza, live, intranasal, quadrivalent
  150http://hl7.org/fhir/sid/cvxinfluenza, injectable, quadrivalent, preservative free
  151http://hl7.org/fhir/sid/cvxinfluenza nasal, unspecified formulation
  152http://hl7.org/fhir/sid/cvxPneumococcal Conjugate, unspecified formulation
  153http://hl7.org/fhir/sid/cvxInfluenza, injectable, MDCK, preservative free
  154http://hl7.org/fhir/sid/cvxHep A, IG
  155http://hl7.org/fhir/sid/cvxinfluenza, recombinant, injectable, preservative free
  156http://hl7.org/fhir/sid/cvxRho(D)-IG
  157http://hl7.org/fhir/sid/cvxRho(D) -IG IM
  158http://hl7.org/fhir/sid/cvxinfluenza, injectable, quadrivalent
  159http://hl7.org/fhir/sid/cvxRho(D) - Unspecified formulation
  160http://hl7.org/fhir/sid/cvxInfluenza A monovalent (H5N1), ADJUVANTED-2013
  161http://hl7.org/fhir/sid/cvxInfluenza, injectable,quadrivalent, preservative free, pediatric
  162http://hl7.org/fhir/sid/cvxmeningococcal B, recombinant
  163http://hl7.org/fhir/sid/cvxmeningococcal B, OMV
  164http://hl7.org/fhir/sid/cvxmeningococcal B, unspecified
  165http://hl7.org/fhir/sid/cvxHPV9
  166http://hl7.org/fhir/sid/cvxinfluenza, intradermal, quadrivalent, preservative free
  167http://hl7.org/fhir/sid/cvxmeningococcal, unknown serogroups
  168http://hl7.org/fhir/sid/cvxinfluenza, trivalent, adjuvanted
  169http://hl7.org/fhir/sid/cvxHep A, live attenuated
  170http://hl7.org/fhir/sid/cvxDTAP/IPV/HIB - non-US
  171http://hl7.org/fhir/sid/cvxInfluenza, injectable, MDCK, preservative free, quadrivalent
  172http://hl7.org/fhir/sid/cvxcholera, WC-rBS
  173http://hl7.org/fhir/sid/cvxcholera, BivWC
  174http://hl7.org/fhir/sid/cvxcholera, live attenuated
  175http://hl7.org/fhir/sid/cvxRabies - IM Diploid cell culture
  176http://hl7.org/fhir/sid/cvxRabies - IM fibroblast culture
  177http://hl7.org/fhir/sid/cvxPCV10
  178http://hl7.org/fhir/sid/cvxOPV bivalent
  179http://hl7.org/fhir/sid/cvxOPV ,monovalent, unspecified
  180http://hl7.org/fhir/sid/cvxtetanus immune globulin
  181http://hl7.org/fhir/sid/cvxanthrax immune globulin
  182http://hl7.org/fhir/sid/cvxOPV, Unspecified
  183http://hl7.org/fhir/sid/cvxYellow fever vaccine - alt
  184http://hl7.org/fhir/sid/cvxYellow fever, unspecified formulation
  185http://hl7.org/fhir/sid/cvxinfluenza, recombinant, quadrivalent,injectable, preservative free
  186http://hl7.org/fhir/sid/cvxInfluenza, injectable, MDCK, quadrivalent, preservative
  187http://hl7.org/fhir/sid/cvxzoster recombinant
  188http://hl7.org/fhir/sid/cvxzoster, unspecified formulation
  189http://hl7.org/fhir/sid/cvxHepB-CpG
  190http://hl7.org/fhir/sid/cvxTyphoid conjugate vaccine (TCV)
  191http://hl7.org/fhir/sid/cvxmeningococcal A polysaccharide (non-US)
  192http://hl7.org/fhir/sid/cvxmeningococcal AC polysaccharide (non-US)
  193http://hl7.org/fhir/sid/cvxHep A-Hep B, pediatric/adolescent
  194http://hl7.org/fhir/sid/cvxInfluenza, Southern Hemisphere
  195http://hl7.org/fhir/sid/cvxDT, IPV adsorbed
  196http://hl7.org/fhir/sid/cvxTd, adsorbed, preservative free, adult use, Lf unspecified
  197http://hl7.org/fhir/sid/cvxinfluenza, high-dose, quadrivalent
  198http://hl7.org/fhir/sid/cvxDTP-hepB-Hib Pentavalent Non-US
  200http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, pediatric, preservative free
  201http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, preservative free
  202http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, quadrivalent, with preservative
  203http://hl7.org/fhir/sid/cvxmeningococcal conjugate quadrivalent, MenACWY-TT (MCV4)
  204http://hl7.org/fhir/sid/cvxEbola Zaire vaccine, live, recombinant, 1mL dose
  205http://hl7.org/fhir/sid/cvxInfluenza vaccine, quadrivalent, adjuvanted
  206http://hl7.org/fhir/sid/cvxVaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection
  207http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
  208http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
  210http://hl7.org/fhir/sid/cvxCOVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
  211http://hl7.org/fhir/sid/cvxCOVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
  212http://hl7.org/fhir/sid/cvxCOVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
  213http://hl7.org/fhir/sid/cvxSARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
  214http://hl7.org/fhir/sid/cvxEbola, unspecified
  215http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF
  216http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF
  217http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose
  218http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose
  219http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose
  220http://hl7.org/fhir/sid/cvxHepB recombinant, 3-antigen, Al(OH)3
  221http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose
  222http://hl7.org/fhir/sid/cvxTick-borne encephalitis, unspecified
  223http://hl7.org/fhir/sid/cvxTick-borne encephalitis, inactivated, PF, 0.25mL
  224http://hl7.org/fhir/sid/cvxTick-borne encephalitis, inactivated, PF, 0.5mL
  225http://hl7.org/fhir/sid/cvxCOVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL
  226http://hl7.org/fhir/sid/cvxCOVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL
  227http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose
  228http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose
  229http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
  230http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL
  231http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, high-dose, quadrivalent
  300http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose
  301http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose
  302http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose
  303http://hl7.org/fhir/sid/cvxRSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF
  304http://hl7.org/fhir/sid/cvxRespiratory syncytial virus (RSV), unspecified
  305http://hl7.org/fhir/sid/cvxRSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF
  306http://hl7.org/fhir/sid/cvxRSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months
  307http://hl7.org/fhir/sid/cvxRSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months
  308http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL
  309http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL
  310http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL
  311http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL
  312http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL
  313http://hl7.org/fhir/sid/cvxCOVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL
  314http://hl7.org/fhir/sid/cvxRespiratory syncytial virus (RSV) vaccine, unspecified
  315http://hl7.org/fhir/sid/cvxRespiratory syncytial virus (RSV) MAB, unspecified
  316http://hl7.org/fhir/sid/cvxmeningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF
  317http://hl7.org/fhir/sid/cvxChikungunya live attenuated vaccine, 0.5 mL, PF
  500http://hl7.org/fhir/sid/cvxCOVID-19 Non-US Vaccine, Product Unknown
  501http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (QAZCOVID-IN)
  502http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (COVAXIN)
  503http://hl7.org/fhir/sid/cvxCOVID-19 LAV Non-US Vaccine (COVIVAC)
  504http://hl7.org/fhir/sid/cvxCOVID-19 VVnr Non-US Vaccine (Sputnik Light)
  505http://hl7.org/fhir/sid/cvxCOVID-19 VVnr Non-US Vaccine (Sputnik V)
  506http://hl7.org/fhir/sid/cvxCOVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology
  507http://hl7.org/fhir/sid/cvxCOVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)
  508http://hl7.org/fhir/sid/cvxCOVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)
  509http://hl7.org/fhir/sid/cvxCOVID-19 PS Non-US Vaccine (EpiVacCorona)
  510http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (BIBP, Sinopharm)
  511http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)
  512http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)
  513http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)
  514http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)
  515http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)
  516http://hl7.org/fhir/sid/cvxCOV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
  517http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)
  518http://hl7.org/fhir/sid/cvxCOVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
  519http://hl7.org/fhir/sid/cvxCOVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
  520http://hl7.org/fhir/sid/cvxCOVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech
  521http://hl7.org/fhir/sid/cvxCOVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK
  801http://hl7.org/fhir/sid/cvxAS03 Adjuvant
  998http://hl7.org/fhir/sid/cvxno vaccine administered
  999http://hl7.org/fhir/sid/cvxunknown
  J07http://www.whocc.no/atcVACCINES
  J07Ahttp://www.whocc.no/atcBACTERIAL VACCINES
  J07AChttp://www.whocc.no/atcAnthrax vaccines
  J07AC01http://www.whocc.no/atcanthrax antigen
  J07ADhttp://www.whocc.no/atcBrucellosis vaccines
  J07AD01http://www.whocc.no/atcbrucella antigen
  J07AEhttp://www.whocc.no/atcCholera vaccines
  J07AE01http://www.whocc.no/atccholera, inactivated, whole cell
  J07AE02http://www.whocc.no/atccholera, live attenuated
  J07AE51http://www.whocc.no/atccholera, combinations with typhoid vaccine, inactivated, whole cell
  J07AFhttp://www.whocc.no/atcDiphtheria vaccines
  J07AF01http://www.whocc.no/atcdiphtheria toxoid
  J07AGhttp://www.whocc.no/atcHaemophilus influenzae B vaccines
  J07AG01http://www.whocc.no/atchaemophilus influenzae B, purified antigen conjugated
  J07AG51http://www.whocc.no/atchaemophilus influenzae B, combinations with toxoids
  J07AG52http://www.whocc.no/atchaemophilus influenzae B, combinations with pertussis and toxoids
  J07AG53http://www.whocc.no/atchaemophilus influenzae B, combinations with meningococcus C, conjugated
  J07AHhttp://www.whocc.no/atcMeningococcal vaccines
  J07AH01http://www.whocc.no/atcmeningococcus A, purified polysaccharides antigen
  J07AH02http://www.whocc.no/atcother meningococcal monovalent purified polysaccharides antigen
  J07AH03http://www.whocc.no/atcmeningococcus A,C, bivalent purified polysaccharides antigen
  J07AH04http://www.whocc.no/atcmeningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen
  J07AH05http://www.whocc.no/atcother meningococcal polyvalent purified polysaccharides antigen
  J07AH06http://www.whocc.no/atcmeningococcus B, outer membrane vesicle vaccine
  J07AH07http://www.whocc.no/atcmeningococcus C, purified polysaccharides antigen conjugated
  J07AH08http://www.whocc.no/atcmeningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
  J07AH09http://www.whocc.no/atcmeningococcus B, multicomponent vaccine
  J07AH10http://www.whocc.no/atcmeningococcus A, purified polysaccharides antigen conjugated
  J07AJhttp://www.whocc.no/atcPertussis vaccines
  J07AJ01http://www.whocc.no/atcpertussis, inactivated, whole cell
  J07AJ02http://www.whocc.no/atcpertussis, purified antigen
  J07AJ51http://www.whocc.no/atcpertussis, inactivated, whole cell, combinations with toxoids
  J07AJ52http://www.whocc.no/atcpertussis, purified antigen, combinations with toxoids
  J07AKhttp://www.whocc.no/atcPlague vaccines
  J07AK01http://www.whocc.no/atcplague, inactivated, whole cell
  J07ALhttp://www.whocc.no/atcPneumococcal vaccines
  J07AL01http://www.whocc.no/atcpneumococcus, purified polysaccharides antigen
  J07AL02http://www.whocc.no/atcpneumococcus, purified polysaccharides antigen conjugated
  J07AL52http://www.whocc.no/atcpneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated
  J07AMhttp://www.whocc.no/atcTetanus vaccines
  J07AM01http://www.whocc.no/atctetanus toxoid
  J07AM51http://www.whocc.no/atctetanus toxoid, combinations with diphtheria toxoid
  J07AM52http://www.whocc.no/atctetanus toxoid, combinations with tetanus immunoglobulin
  J07ANhttp://www.whocc.no/atcTuberculosis vaccines
  J07AN01http://www.whocc.no/atctuberculosis, live attenuated
  J07APhttp://www.whocc.no/atcTyphoid vaccines
  J07AP01http://www.whocc.no/atctyphoid, oral, live attenuated
  J07AP02http://www.whocc.no/atctyphoid, inactivated, whole cell
  J07AP03http://www.whocc.no/atctyphoid, purified polysaccharide antigen
  J07AP10http://www.whocc.no/atctyphoid, combinations with paratyphi types
  J07ARhttp://www.whocc.no/atcTyphus (exanthematicus) vaccines
  J07AR01http://www.whocc.no/atctyphus exanthematicus, inactivated, whole cell
  J07AXhttp://www.whocc.no/atcOther bacterial vaccines
  J07Bhttp://www.whocc.no/atcVIRAL VACCINES
  J07BAhttp://www.whocc.no/atcEncephalitis vaccines
  J07BA01http://www.whocc.no/atcencephalitis, tick borne, inactivated, whole virus
  J07BA02http://www.whocc.no/atcencephalitis, Japanese, inactivated, whole virus
  J07BA03http://www.whocc.no/atcencephalitis, Japanese, live attenuated
  J07BBhttp://www.whocc.no/atcInfluenza vaccines
  J07BB01http://www.whocc.no/atcinfluenza, inactivated, whole virus
  J07BB02http://www.whocc.no/atcinfluenza, inactivated, split virus or surface antigen
  J07BB03http://www.whocc.no/atcinfluenza, live attenuated
  J07BB04http://www.whocc.no/atcinfluenza, virus like particles
  J07BChttp://www.whocc.no/atcHepatitis vaccines
  J07BC01http://www.whocc.no/atchepatitis B, purified antigen
  J07BC02http://www.whocc.no/atchepatitis A, inactivated, whole virus
  J07BC20http://www.whocc.no/atccombinations
  J07BDhttp://www.whocc.no/atcMeasles vaccines
  J07BD01http://www.whocc.no/atcmeasles, live attenuated
  J07BD51http://www.whocc.no/atcmeasles, combinations with mumps, live attenuated
  J07BD52http://www.whocc.no/atcmeasles, combinations with mumps and rubella, live attenuated
  J07BD53http://www.whocc.no/atcmeasles, combinations with rubella, live attenuated
  J07BD54http://www.whocc.no/atcmeasles, combinations with mumps, rubella and varicella, live attenuated
  J07BEhttp://www.whocc.no/atcMumps vaccines
  J07BE01http://www.whocc.no/atcmumps, live attenuated
  J07BFhttp://www.whocc.no/atcPoliomyelitis vaccines
  J07BF01http://www.whocc.no/atcpoliomyelitis oral, monovalent, live attenuated
  J07BF02http://www.whocc.no/atcpoliomyelitis oral, trivalent, live attenuated
  J07BF03http://www.whocc.no/atcpoliomyelitis, trivalent, inactivated, whole virus
  J07BF04http://www.whocc.no/atcpoliomyelitis oral, bivalent, live attenuated
  J07BGhttp://www.whocc.no/atcRabies vaccines
  J07BG01http://www.whocc.no/atcrabies, inactivated, whole virus
  J07BHhttp://www.whocc.no/atcRota virus diarrhea vaccines
  J07BH01http://www.whocc.no/atcrota virus, live attenuated
  J07BH02http://www.whocc.no/atcrota virus, pentavalent, live, reassorted
  J07BJhttp://www.whocc.no/atcRubella vaccines
  J07BJ01http://www.whocc.no/atcrubella, live attenuated
  J07BJ51http://www.whocc.no/atcrubella, combinations with mumps, live attenuated
  J07BKhttp://www.whocc.no/atcVaricella zoster vaccines
  J07BK01http://www.whocc.no/atcvaricella, live attenuated
  J07BK02http://www.whocc.no/atczoster, live attenuated
  J07BK03http://www.whocc.no/atczoster, purified antigen
  J07BLhttp://www.whocc.no/atcYellow fever vaccines
  J07BL01http://www.whocc.no/atcyellow fever, live attenuated
  J07BMhttp://www.whocc.no/atcPapillomavirus vaccines
  J07BM01http://www.whocc.no/atcpapillomavirus (human types 6, 11, 16, 18)
  J07BM02http://www.whocc.no/atcpapillomavirus (human types 16, 18)
  J07BM03http://www.whocc.no/atcpapillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)
  J07BXhttp://www.whocc.no/atcOther viral vaccines
  J07BX01http://www.whocc.no/atcsmallpox vaccines
  J07BX02http://www.whocc.no/atcebola vaccines
  J07Chttp://www.whocc.no/atcBACTERIAL AND VIRAL VACCINES, COMBINED
  J07CAhttp://www.whocc.no/atcBacterial and viral vaccines, combined
  J07CA01http://www.whocc.no/atcdiphtheria-poliomyelitis-tetanus
  J07CA02http://www.whocc.no/atcdiphtheria-pertussis-poliomyelitis-tetanus
  J07CA03http://www.whocc.no/atcdiphtheria-rubella-tetanus
  J07CA04http://www.whocc.no/atchaemophilus influenzae B and poliomyelitis
  J07CA05http://www.whocc.no/atcdiphtheria-hepatitis B-pertussis-tetanus
  J07CA06http://www.whocc.no/atcdiphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus
  J07CA07http://www.whocc.no/atcdiphtheria-hepatitis B-tetanus
  J07CA08http://www.whocc.no/atchaemophilus influenzae B and hepatitis B
  J07CA09http://www.whocc.no/atcdiphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
  J07CA10http://www.whocc.no/atctyphoid-hepatitis A
  J07CA11http://www.whocc.no/atcdiphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B
  J07CA12http://www.whocc.no/atcdiphtheria-pertussis-poliomyelitis-tetanus-hepatitis B
  J07CA13http://www.whocc.no/atcdiphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C
  J07Xhttp://www.whocc.no/atcOTHER VACCINES

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code